GENE ONLINE|News &
Opinion
Blog

Envisioning a Future of Superior, Cost-Effective Healthcare: An interview with Dr. Jeong-Sun Seo

by Thomas F. Huang
Share To
The rise of South Korean biotechnology is a recent one and goes back to the late 1990s when the first South Korean biotech company, Macrogen Inc. was formed. Since then, it has come a long way with its chairman and founder, Dr. Jeong-Sun Seo serving as the catalyst behind its growth. At the 2019 annual BIOPlus event, GeneOnline exclusively interviewed Dr. Seo, who is also the president of KoreaBIO (Korea Biotechnology Industry Organization).

It's free! Log in now to read

LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top